Rivastigmin kan, som en kolinesterasehæmmer, muligvis forstærke virkningerne af muskelrelaksantia af succinylkolintypen under anæstesi.
As a cholinesterase inhibitor, rivastigmine may exaggerate the effects of succinylcholine-type muscle relaxants during anaesthesia.